secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solana Co (HSDT)
CIK:        0001610853
Form:       8-K
Filed at:   2024-08-12T23:59:59+00:00
Accession:  0001558370-24-011901
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Helius Medical Q2 revenue $182K (down 29% YoY); secures first insurance reimbursement for PoNS at $23,900
--------------------------------------------------------------------------------

- Revenue $182K vs $256K YoY due to PTAP termination; up 35% sequentially from Q1 2024.
- Net loss $1.6M flat YoY; EPS -$0.64 vs -$2.92; cash $6.4M, no debt, runway into 2025.
- First third-party insurance reimbursement secured at $23,900 for PoNS; CMS final rate due Oct 1.
- Completed enrollment in stroke registrational program; FDA submission targeted H1 2025.
- VA and DoD contract prices set at ~$23,800/$7,300 for device/mouthpiece; VA sales build underway.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610853/000155837024011901/0001558370-24-011901-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610853/000155837024011901/hsdt-20240812x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-011901

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer